(Q51400308)

English

A Bayesian adaptive design for multi-dose, randomized, placebo-controlled phase I/II trials.

scientific article published on 9 March 2012

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22426247

retrieved

4 April 2018

reference URL

http://europepmc.org/abstract/MED/22426247

title

A Bayesian adaptive design for multi-dose, randomized, placebo-controlled phase I/II trials. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22426247

retrieved

4 April 2018

reference URL

http://europepmc.org/abstract/MED/22426247

main subject

phase II clinical trial

0 references

phase I clinical trial

0 references

1 reference

Fang Xie

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22426247

retrieved

4 April 2018

reference URL

http://europepmc.org/abstract/MED/22426247

Yuan Ji

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22426247

retrieved

4 April 2018

reference URL

http://europepmc.org/abstract/MED/22426247

Lothar Tremmel

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22426247

retrieved

4 April 2018

reference URL

http://europepmc.org/abstract/MED/22426247

language of work or name

English

0 references

publication date

9 March 2012

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22426247

retrieved

4 April 2018

reference URL

http://europepmc.org/abstract/MED/22426247

published in

Contemporary Clinical Trials

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22426247

retrieved

4 April 2018

reference URL

http://europepmc.org/abstract/MED/22426247

volume

33

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22426247

retrieved

4 April 2018

reference URL

http://europepmc.org/abstract/MED/22426247

issue

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22426247

retrieved

4 April 2018

reference URL

http://europepmc.org/abstract/MED/22426247

page(s)

739-748

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22426247

retrieved

4 April 2018

reference URL

http://europepmc.org/abstract/MED/22426247

Identifiers

DOI

10.1016/J.CCT.2012.03.001

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22426247

retrieved

4 April 2018

reference URL

http://europepmc.org/abstract/MED/22426247

PubMed publication ID

22426247

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22426247

retrieved

4 April 2018

reference URL

http://europepmc.org/abstract/MED/22426247

ResearchGate publication ID

221714682

0 references

(Q51400308)

A Bayesian adaptive design for multi-dose, randomized, placebo-controlled phase I/II trials.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)